Payments to Acquire Property, Plant, and Equipment of CATALYST PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
CATALYST PHARMACEUTICALS, INC. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • CATALYST PHARMACEUTICALS, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $0, a 100% decline year-over-year.
  • CATALYST PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $58,000, a 90% decline from 2024.
  • CATALYST PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $556,000, a 141% increase from 2023.
  • CATALYST PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $231,000, a 697% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

CATALYST PHARMACEUTICALS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $58,000 -$498,000 -90% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $556,000 +$325,000 +141% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $231,000 +$202,000 +697% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $29,000 -$992,000 -97% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 $1,021,000 +$1,010,000 +9182% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $11,000 -$8,000 -42% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2023 2022 FY
2019 $19,000 -$73,018 -79% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2022 2021 FY
2018 $92,018 01 Jan 2018 31 Dec 2018 10-K 15 Mar 2021 2020 FY
2016 $96,061 +$72,596 +309% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2018 2017 FY
2015 $23,465 -$33,858 -59% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
2014 $57,323 +$47,891 +508% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
2013 $9,432 -$42,950 -82% 01 Jan 2013 31 Dec 2013 10-K 15 Mar 2016 2015 FY
2012 $52,382 +$48,762 +1347% 01 Jan 2012 31 Dec 2012 10-K 13 Mar 2015 2014 FY
2011 $3,620 +$753 +26% 01 Jan 2011 31 Dec 2011 10-K 19 Mar 2014 2013 FY
2010 $2,867 01 Jan 2010 31 Dec 2010 10-K 01 Apr 2013 2012 FY

CATALYST PHARMACEUTICALS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 -$199,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q1 2024 $199,000 +$125,000 +169% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q1 2023 $74,000 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2021 $911,000 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2019 $5,633 +$5,633 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $0 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q1 2015 $7,910 -$9,396 -54% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $17,306 +$7,873 +83% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q1 2013 $9,433 +$4,452 +89% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q1 2012 $4,981 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.